Navigation Links
Simbionix Increases Product Offerings for OB/GYN Physicians

CLEVELAND and ZURICH, Switzerland, March 11 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, and VirtaMed, a Swiss medical engineering company, announced today a global collaboration agreement. Simbionix will exclusively distribute, market, and provide service for the VirtaMed HystSim, an advanced virtual reality hysteroscopy simulator.

Simbionix already offers a wide spectrum of simulators for minimal invasive surgery. "This new agreement further expands our product offering," says Simbionix CEO Gary Zamler. "The addition of the HystSim simulator, along with our recently launched laparoscopic surgery module for gynecology, shows how seriously Simbionix is investing in women's healthcare issues".

Simbionix' President and founder, Mr. Ran Bronstein, adds: "Our simulation technology is definitely a revolution in the world of medical training and assessment. We are happy to be working together with VirtaMed, a company as committed to technology and simulation quality as we are. Simbionix will keep increasing its product offering to the medical community and bring quality and service to its customers and partners."

"VirtaMed is thrilled to be working together with Simbionix, the market leader in surgical simulation," adds VirtaMed CEO Stefan Tuchschmid. "Simbionix is a partner that will ensure the HystSim simulator is available globally. We truly appreciate Simbionix' commitment to provide the best possible training for surgeons in every field."

VirtaMed HystSim(TM) will be officially launched at the next ACOG (American College of Obstetricians and Gynecologists) annual clinical meeting held in Chicago on May 2nd.

Further information and product demonstrations are available from your local Simbionix sales representative and at

About VirtaMed

VirtaMed is a Swiss based company with an interdisciplinary background in medicine and engineering. The HystSim(TM) system is the first VirtaMed product and provides instructional teaching and training of diagnostic and therapeutic hysteroscopy. VirtaMed's mission is to develop state-of-the-art training tools for endoscopic surgery of highest possible realism, all with the ultimate goal to improve the quality of patient care. Additional company information can be found at

About Simbionix

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. Visit

    Inbal Mazor
    VP Marketing
    Tel: +972-8-9211177

SOURCE Simbionix Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
2. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
3. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
4. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
5. Simbionix Launches Innovative Patient-Specific Simulation
6. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
7. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
8. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
9. R&D Spending by U.S. Biopharmaceutical Companies Increases 3 Percent in 2008
10. Despite Economic Woes, Physician Compensation Increases
11. Gerresheimer Substantially Increases Quarterly Operating Profit
Post Your Comments:
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
(Date:11/24/2015)... -- Cepheid (NASDAQ: CPHD ) today announced that ... and invited investors to participate via webcast. ... 1, 2015 at 11.00 a.m. Eastern Time --> ... 1, 2015 at 11.00 a.m. Eastern Time --> ... NY      Tuesday, December 1, 2015 at 11.00 ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended September ... in Canadian dollars and presented under International Financial ... States ," said Andrew Rae , ... regarding iCo-008 are not only value enriching for ...
(Date:11/24/2015)... ... 24, 2015 , ... International Society for Pharmaceutical Engineering (ISPE) ... annual events for pharmaceutical manufacturing: 2015 Annual Meeting. The conference took place in ... largest number of attendees in more than a decade. , “The 2015 ...
Breaking Biology Technology:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... 29, 2015 Daon, a global leader in ... released a new version of its IdentityX Platform ... North America have already installed IdentityX v4.0 ... a FIDO UAF certified server component as ... activate FIDO features. These customers include some of the ...
(Date:10/29/2015)... NXTD ) ("NXT-ID" or ... the growing mobile commerce market and creator of ... leading marketplace to discover and buy innovative technology ... on StackSocial for this holiday season.   ... a biometric authentication company focused on the growing ...
Breaking Biology News(10 mins):